Archive for spesolimab-sbzo (Spevigo)

Spevigo is indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older weighing at least 40 kg.
Boehringer Ingelheim Pharmaceuticals, Inc.